• Strategic Planning: Established foundation and shaped 3 pillar initiatives: multiple event series inbiotech hubs; pharma to startup mentoring program; next generation career initiative. Expanding to awarding grant funding.• Program Design & Execution: Co-authored and led 5-year strategic plan centered on domestic and international expansion.Within 12 months, hosted 5,000+ lifesci professionals (VC, founder, pharma, etc.) across 8 cities through monthly events.• Business Development: Devised strategy to bring on 50+ partnerships and sponsors for projected annual $500K sponsorship.

Hosting happy hours across biotech hubs

Implemented the clinical technology transfer of Altropane, a next generation DAT SPECT imaging agent, into the Pharmaceutical Diagnostics business Designed and implemented USA based clinical trials with various R&D functional leadersAuthored clinical, regulatory, and business case documents in collaboration with SMEs to support New Product Initiatives within the R&D neurology portfolioDeveloped and maintained the USA and EU scientific strategy for the Neurology imaging programs with internal teams and external partners

Facilitated partnership discussions which led to multiple offers for development and commercialization in the USA, Europe, and Japan, and resulted in a global licensing deal with GE Healthcare Conducted industry diligence, competitive landscape analysis, andrepresented the company at investor events.De‑risked funding by organizing successful royalty renegotiationPerformed an audit and gap analysis for 7 historic sponsored studiesCo‑authored patents concerning radiotracer dosing and imagingSourced and implemented project management software based on companyneeds

Implemented machine learning algorithms with TensorFlow in Python to analyze data from a medical device to enhance patient safety and usabilityCollected a clean and reliable data set from multiple medical devices for future algorithm testingCommunicated project status in weekly progress meetings with the control systems development teamEvaluated the regulatory environment for the medical device industry and produced a reimbursement primer for the DEKA business development team.

Facilitated clinical research projects and technology solutions to improve the management of patients with brain injuries requiring neurocritical care for seizure disorders, traumatic brain injury, and brain hemorrhageMaintained and oversaw regulatory documentation, IRB applications, optimized study management, collected and processed biological samplesAchieved highest site patient enrollment and dosing in a global, phase III, double blind, inpatient studyCoordinated 12 projects including the SAGE - 547 Super Refractory Status Epilepticus Phase III Trial, UCB EP0087- Brivaracetam v. Lorazepam Phase II Trial in the Epilepsy Monitoring Unit, RNS System Long-Term Treatment Clinical Investigation, RNS System Post-Approval Study in Epilepsy, The Human Epilepsy Project, an Epilepsy Monitoring Unit Tissue Repository in collaboration with Quanterix, InsomniSolv Field Study of Zziesta, a post surgery epilepsy monitoring database, and a collaborative genetic study with Boston Children’s Hospital

Evaluated patient care in vulnerable populations in the Neurovalue Lab of Lidia Moura M.D., M.P.H. as well as edited manuscripts and created databases from dedicated Research Patient Data Registry (RPDR) Queries

Developed dental devices to increase angiogenesis in gingival tissue based on published research on negative pressure and wound healing in Wounds by Dr. Oksana Budinskaya Evaluated investor opportunities with legal entities and private sector companies as well as drafting budgets and plans for secondary animal studies with experienced advisorsDesigned and then tested a negative and positive pressure device as well as a vacuum pump via COMSOL simulations and catastrophic failure testing during senior year of university at SyracusePlaced 3rd in the Syracuse University Panasci Business Competition 2016 as well as won the Award for Consumer Product Innovation and Design

Fabricated components for use in model simulators of particle detectors in the Large Hadron Collider with the LHCb Collaboration .Cataloged large sets of material quantities and properties.

Research assistant through the EFRI-REM Research Experience and Mentorship program Collaborated on a project concerning the formation of bacterial biofilms and studied the expression of the luxS gene, responsible for the signalling molecule AI-2, by labeling the gene promoter with a green fluorescent protein.